Advertisement

$ 51.62
16:19 01/30/2009
Change: +1.16 +2.3% | Volume: 4,523,550
Pharmaceutical
Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis
Jul 28, 2010 10:45AM
Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate hydrofluoroalkane Nasal Aeros...

Teva Pharmaceutical Industries Ltd. (TEVA), Pharmaceutical, Hospitals, Biotechnology, Pennsylvania


About IBT PR Center
The IBTAnnouncement Service helps investors discover the latest information reported by companies in which they are invested, including changes in voting rights, net asset values, and more.

advertisement

Popular Tags

advertisement